Running hot in customers' hands: existing deployments are being used harder than they were sized for
The model's full reasoning — Q3 2021 call → NOWe need to determine if management describes that the company's product/service/capacity is already deployed and being used more intensively by existing customers than originally expected, with heavier usage observable in current business. The transcript discusses Alignment Healthcare's operations. Key points: They have a platform AVA, care model, etc. They report membership growth, revenue, MBR, etc. They talk about improvements in AVA, stratification models, etc. But the question is about existing customers using the product more intensively than expected. The transcript mentions "we continue to improve our stratification model" and "we are able to accurately predict the highest risk 10% of our members who will represent 50% of inpatient admissions" - that's about predictive capability, not about usage intensity. They talk about "Care Anywhere clinical teams put AVA’s workflow tool to use" - that's internal use. They mention "we continue to invest in the business intelligence modules of AVA" - that's investment. They talk about membership growth, revenue growth, but that's about adding members, not about existing members using more. They mention "our most recent NPS of 82" - that's satisfaction. They talk about Star Ratings, HEDIS scores. They discuss DCE performance, but that's about a new program. The question is specifically about "existing customers" using the product more intensively than originally sized. The transcript does not describe any phenomenon where existing members are consuming more services or using the platform more than expected. Instead, growth is described as adding new members, new markets, new products. There is no mention of existing members increasing usage per member. In fact, they talk about utilization being lower than baseline (4-5% below normalized 3Q baseline). So utilization is actually lower, not higher. Thus, the answer is NO. We need to answer only YES or NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| APYX | Apyx Medical Corporation | Q4 2023 | 2024-03-21 | C |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| GEO | The GEO Group, Inc. | Q2 2016 | 2016-08-02 | B+ |
TJX · Q2 2021 → YESThe question is about whether management describes that the company's product, service, capacity, or offering — already deployed with existing customers — is being used more intensively than originall...
WES · Q3 2018 → YESThe question is about whether management describes that the company's product, service, capacity, or offering — already deployed with existing customers — is being used more intensively than originall...
BCE · Q2 2017 → YESThe question is about whether management describes that the company's product, service, capacity, or offering — already deployed with existing customers — is being used more intensively than originall...